NEW YORK, December 1, 2016 /PRNewswire/ --
Today, Stock-Callers.com takes a look at the Healthcare REITs, which was the weakest performing REIT sector over the prior quarter, down more than 18% since mid-August, due to factors such as rising Treasury bond yields, policy uncertainty, and mixed third-quarter earnings. Equities to assess today are: Omega Healthcare Investors Inc. (NYSE: OHI), Physicians Realty Trust (NYSE: DOC), Healthcare Trust of America Inc. (NYSE: HTA), and Care Capital Properties Inc. (NYSE: CCP). Learn more about these stocks by downloading their free report at:
Omega Healthcare Investors
Maryland, US-based Omega Healthcare Investors Inc.'s stock finished Wednesday's session 0.51% lower at $29.46. A total volume of 3.26 million shares was traded, which was above their three months average volume of 2.37 million shares. The Company's shares are trading below their 50-day moving average by 6.90%. Furthermore, shares of Omega Healthcare Investors, which invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio, have a Relative Strength Index (RSI) of 44.61.
On November 02nd, 2016, Omega Healthcare announced that Second Spring Healthcare Investments, a joint venture approximately 85% owned by affiliates of Lindsay Goldberg LLC and approximately 15% owned by an affiliates of Omega, acquired 64 facilities from Welltower, Inc. for $1.1 billion. Simultaneously, affiliates of Second Spring entered into a new 15-year Master Lease with certain subsidiaries of Genesis Healthcare. The free research report on OHI is available at:
Physicians Realty Trust
On Wednesday, shares in Milwaukee, Wisconsin-based Physicians Realty Trust ended at $18.12, down 2.21% from the last trading session. The stock recorded a trading volume of 1.17 million shares. The Company's shares have gained 12.66% since the start of this year. The stock is trading 6.11% below its 200-day moving average. Moreover, shares of Physicians Realty Trust, which focuses on the acquisition, development, ownership, and management of healthcare properties that are leased to physicians, hospitals, and healthcare delivery systems, have an RSI of 41.29.
On November 02nd, 2016, Physicians Realty reported that total revenue for Q3 2016 was $70.0 million, an increase of 101% from Q3 2015. Total expenses for Q3 2016 were $59.7 million compared to $31.1 million in Q3 2015, or an increase of 92%. Net income for Q3 2016 grew to $10.3 million compared to net income of $4.0 million for Q3 2015.
On November 07th, 2016, research firm Raymond James upgraded the Company's stock rating from 'Market Perform' to 'Strong Buy'. The complimentary report on DOC can be downloaded at:
Healthcare Trust of America
Scottsdale, Arizona-based Healthcare Trust of America Inc.'s stock ended yesterday's session 2.18% lower at $28.28, with a total trading volume of 816,459 shares. The Company's shares have advanced 7.85% on an YTD basis. The stock is trading 6.79% below its 200-day moving average. Additionally, shares of Healthcare Trust of America, which invests in the real estate markets of the US, have an RSI of 40.82.
On November 07th, 2016, research firm Raymond James upgraded the Company's stock rating from 'Market Perform' to 'Outperform'. Visit us today and download our complete research report on HTA for free at:
Care Capital Properties
At the close on Wednesday, shares in Chicago, Illinois-based Care Capital Properties Inc. recorded a trading volume of 1.06 million shares, which was higher than their three months average volume of 658,510 shares. The stock finished 0.04% lower at $24.08. The Company's shares are trading below their 50-day moving average by 7.24%. Furthermore, shares of Care Capital Properties, which focuses on owning, acquiring, and leasing skilled nursing facilities and other healthcare assets operated by private regional and local care providers in the US, have an RSI of 44.20.
On November 10th, 2016, Care Capital Properties reported that net income attributed to the Company for Q3 2016 was $19 million, or $0.23 per diluted common share, compared to $36 million, or $0.43 per diluted common share, in Q3 2015. Normalized Funds from Operations for Q3 2016 was $63 million, or $0.75 per diluted common share, compared to $70 million, or $0.84 per diluted common share, in Q3 2015.
On November 11th, 2016, research firm Mizuho reiterated its 'Buy' rating on the Company's stock with a decrease of the target price from $34 a share to $26 a share. Get free access to your technical report on CCP at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA